
NewDays, a Seattle startup utilizing a generative AI remedy to deal with individuals with gentle dementia, has added $4.5 million to a latest seed funding spherical.
The corporate confirmed the increase this week after GeekWire noticed a regulatory submitting. Whole funding is now $11.5 million after NewDays beforehand introduced a $7 million investment in early September.
The corporate presents telehealth visits with clinicians a few times a month mixed with frequent, customized conversations with an AI companion referred to as Sunny. The AI-led conversations present particular varieties of therapies together with cognitive stimulation, cognitive coaching and cognitive rehabilitation.
Co-founder and CEO founder Babak Parviz launched the startup final 12 months with Chief Innovation Officer Daniel Kelly. Parviz was a vp at Amazon the place he led the corporate’s Grand Problem initiative to find new areas of operation. Previous to that position, he was at Google X and ran the Google Glass staff. Kelly beforehand oversaw engineering groups at Amazon and Google X.
NewDays plans to make use of the recent money to extend its funding in synthetic intelligence expertise and development.
The startup, which costs a month-to-month $99 subscription payment and likewise accepts medical insurance, says it’s producing income, however isn’t but sharing info associated to what number of clients it has attracted.
Seattle’s Madrona Venture Group and San Francisco’s General Catalyst are early backers.
Parviz and Kelly appeared on the “Based & Funded” podcast this week (under) with Madrona Managing Director Tim Porter during which they mirrored on why now’s the second to sort out cognitive decline with AI, mixing scientific rigor with human empathy.
“There was a large unmet want, and there was a radically new expertise accessible that would carry medically confirmed interventions to a lot of individuals,” Parviz stated.
The dialog underscored how the pair’s expertise at Amazon and Google formed their drive for “significant velocity” — shifting quick not simply to innovate, however to make a measurable distinction in individuals’s lives.